[SRNE] QoQ Quarter Result on 31-Mar-2021 [#Q1]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
05-May-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- 103.51%
YoY- 103.85%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 13,076 12,062 13,511 14,255 11,505 11,753 9,007 28.12%
PBT -178,068 -119,773 -167,340 2,212 -73,068 -86,398 -82,213 67.16%
Tax -33,055 386 -641 -206 36 145 -1,919 563.52%
NP -144,417 -119,803 -166,615 2,510 -71,502 -84,023 -77,740 50.94%
Tax Rate - - - 9.31% - - - -
Total Cost 157,493 131,865 180,126 11,745 83,007 95,776 86,747 48.66%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin -1,104.44 -993.23 -1,233.18 17.61 -621.49 -714.91 -863.11 17.81%
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
EPS -0.47 -0.40 -0.57 0.01 -0.28 -0.33 -0.36 19.39%
EPS Diluted -0.47 -0.40 -0.57 0.01 -0.28 -0.33 -0.36 19.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.